H1B Salary Data

Home › Occupations › Medical Scientists, Except Epidemiologists › Houston, TX

Medical Scientists, Except Epidemiologists in Houston, TX: H-1B salaries

953 labor condition applications for this occupation with a work site in Houston, TX. Median offered base salary $68,244; middle half $62,000–$77,050.

Applications (LCAs)953
Median offered salary$68,244
Middle half of salaries$62,000–$77,050
10th–90th percentile$56,484–$91,237

By wage level

Wage levelMedian salary
Level I (entry)$67,179
Level II (qualified)$78,873
Level III (experienced)$95,000
Level IV (fully competent)$116,446

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Employers

EmployerLCAsMedian salary
Baylor College of Medicine354$66,228
The University of Texas M.D. Anderson Cancer Center299$76,005
The University of Texas Health Science Center at Houston140$65,780
The Methodist Hospital Research Institute105$65,160
University of Houston15$59,758
Texas A&M University9$61,567
Texas Heart Institute4$100,000
Biopharma Informatic, LLC4$65,000
Lonza Houston Inc3$95,754
Varian Medical Systems, Inc.2$251,074
Education, Research and Health International, Inc.2$62,746
Ge Precision Healthcare LLC2$125,400
CooperSurgical, Inc.2$75,250
The Methodist Hospital2$56,504
Texas Children's Hospital2$60,026
Elite Bio-Reference Laboratory, Inc.1$170,000
Dualitybio Inc.1$63,000
Mercury Clinical Research, Inc.1$56,451
Idriss Mobarak Inc1$66,800
Yvonne Kew MD PLLC1$75,400
RadioMedix, Inc.1$90,000
ImmunoGenesis, Inc.1$85,000
Research Update Inc.1$55,224

Job titles

H-1B sponsors in Houston, TX →

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).